Brief: Desmopressin Newbury Approved By Swedish Health Authorities
July 19 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* DESMOPRESSIN NEWBURY APPROVED BY THE SWEDISH HEALTH
AUTHORITIES
* APPROVALS IN NORWAY AND DENMARK ARE EXPECTED TO FOLLOW
UPON
FINALIZED NATIONAL REVIEWS
Source text for Eikon: ID:nMFNb790Yr
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln